Patent Settlements in the Pharmaceutical Industry: What Can We Learn From Economic Analysis?
Patent settlements between originator and generic firms in the pharmaceutical industry have been challenged by antitrust and competition authorities in the U.S. and the EU. Particularly settlementswith large "reverse payments" to generic firms raise the concern of collusive behaviour for p...
Salvato in:
| Pubblicato in: | MAGKS - Joint Discussion Paper Series in Economics (Band 01-2016) |
|---|---|
| Autori principali: | , |
| Natura: | Articolo |
| Lingua: | inglese |
| Pubblicazione: |
Philipps-Universität Marburg
2015
|
| Soggetti: | |
| Accesso online: | PDF Full Text |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
No citations were found for this record.